Short answer
KORU Medical Systems, Inc. (KRMD) filed its Q3 2025 10-Q quarterly report on Nov 12, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $10M (up 27.2% year over year) with net income of −$777,965.
Q3 2025 key financials · XBRL
- Revenue
- $10M
- +27.2% YoY · +2.0% QoQ
- Net income
- −$777,965
- +50.8% YoY · −276.1% QoQ
- Operating margin
- -8.3%
- Gross margin
- 60.2%
- EPS (diluted)
- $0.02
- +150.0% YoY
Source: XBRL data from the KORU Medical Systems, Inc. (KRMD) Q3 2025 10-Q on SEC EDGAR. USD.
KORU Medical Systems, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $10.4M, up 27.2% YoY from $8.2M
- Gross margin 60.2% vs 63.4% YoY; net loss $0.8M vs $1.6M
- International Core best performer: $3.7M, up 229.6% YoY
- Domestic Core weakest segment: $6.1M, down 5.0% YoY
- Cash $8.5M; nine-month operating cash use $0.6M vs $1.3M; tariff charges $0.1M with annualized margin impact under 100 basis points
Risk Factors
- Risk-factor text absent, preventing identification of newly added or materially updated risks
- No regulatory, legal, operational, competitive, market, or financial risk details provided
- Filing references the 2024 10-K and March 31, 2025 10-Q without describing changes
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other KORU Medical Systems, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.